Clinical Trials
33 trialsNatural History Study of Early Life Exposures in Agriculture (ELEA)
National Institutes of Health Clinical Center (CC)
SURVIMON
N.N. Petrov National Medical Research Center of Oncology
National Cancer Institute "Cancer Moonshot Biobank"
National Cancer Institute (NCI)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Alliance for Clinical Trials in Oncology
LONGEVITI
University of Alberta
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
University of Florida
iCaRe2
University of Nebraska
DP-04
AstraZeneca
CER
Cancer Support Community, Research and Training Institute, Philadelphia
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Washington University School of Medicine
SCORE
Natera, Inc.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
SBRT
Mayo Clinic
Tempus Priority Study: A Pan-tumor Observational Study
Tempus AI
Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics
Mayo Clinic
Eligibility Screening for the NIH Intramural Research Program Clinical Protocols
National Institutes of Health Clinical Center (CC)
PREFER
Labcorp Corporation of America Holdings, Inc
MOHCCN-O
University Health Network, Toronto
ROOT
Taproot Health
QUANTUM
VitaMed Research LLC
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
National Institutes of Health Clinical Center (CC)
REGATA
N.N. Petrov National Medical Research Center of Oncology
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Sanguine Biosciences
Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study
Namida Lab
Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease
National Institutes of Health Clinical Center (CC)
HSP70CTC
Charite University, Berlin, Germany
PIONEER
SpeciCare
E-MOSAIC Electronic Tool to Monitor Symptoms
Swiss Cancer Institute
N1
CureOne
Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers
Cota Inc.
CTC
Comprehensive Cancer Centers of Nevada
Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants
Wake Forest University Health Sciences
B-Receptor Signaling in Cardiomyopathy
Stanford University